Global Biochemistry Conferences
(5 Plenary Forums-1 Event)
Dec 8-9 2016 | San Antonio, USA
August 31-September 01, 2017 | Philadelphia, USA
Theme: Rise of New Era in Metabolomics Research
Metabolomics Congress 2017
Conference Series LLC 8th International Conference and Exhibition on Metabolomics during May 11-13, 2017 Singapore. The attending delegates include Editorial Board Members of related OMICS Group Journals. This is a fabulous open door for the representatives from Universities and Institutes to communicate with the world class Scientists.
Metabolomics Congress 2017 Conference will be an investigation of New research Innovation of Metabolomics and spread the most recent advancements and patterns in Metabolomics displaying, Proteomics, Systems Biology, Genomics, Precision Medicine, Lipidomics, LC-MS and GC-MS Techniques, Bioinformatics, Plant Metabolomics, Clinical metabolomics, tumor and digestion system, computational science, metabolomics disorder, Nutritional Metabolomics, Therapeutic Metabolomics and more. Metabolomics is of enthusiasm to doctors in light of the fact that it might prompt enhancements in the conclusion and medications of human illnesses. Metabolomics as an order makes utilization of systematic procedures, for example, spectroscopy, chromatography, and multivariable investigation. Metabolomics permits researchers to gauge physiological impacts and to screen for unfavorable responses to tranquilizes.
Theme: Rise of New Era in Metabolomics Research
Track 1 : Cancer Therapeutic Approaches
Cancer biomarkers have expanded immensely giving extraordinary chances to enhancing so as to enhance the administration of disease patients the proficiency of discovery and viability of treatment. Late innovative headway has empowered the examination of numerous potential biomarkers and recharged enthusiasm for growing new biomarkers. Biomarkers of disease could incorporate a wide scope of biochemical elements, for example, nucleic acids, proteins, sugars, lipids, and little metabolites, cytogenetic and cytokinetic parameters and additionally entire tumor cells found in the body liquid. A far reaching comprehension of the pertinence of each biomarker will be vital for diagnosing the illness dependably, as well as help in the decision of different remedial options as of now accessible that is prone to advantage the patients. A biological molecule found in blood, other body liquids, or tissues that is an indication of a typical or strange procedure, or of a condition or sickness. A biomarker might be utilized to perceive how well the body reacts to a treatment for a sickness or condition. Also called molecular marker and signature molecule.
Track 2 : Metabolic Syndrome
Metabolomic profiling has been used to recognize novel biomarkers and instruments of cardiovascular malady hazard. Support and Metabolism Center and Center for Human Genetics at Duke University where the examination is proceeding with National Institutes of Health grants .Metabolomics can give certain inclinations in admiration to other "omics" progressions in diabetes research. CEDAM (Center for Endocrinology, Diabetes and Metabolism) investigation is centered around a seat to-bedside approach, taking examination through from essential science exposure to clinical application. Metabolomic approach gives novel encounters into the robotic investigations of antitumor prescriptions from a point specific from customary pharmaceutical examinations. Metabolic profiling is the multiparallel relative evaluation of a blend of mixes or compound classes utilizing chromatography and all inclusive discovery advancements (GC-MS, LCMS). Metabolic profiling can supplement routine frameworks and other "omics" propels in inquiring about preclinical prescription change issues.
Track 3 : Metabolomics in Precision Medicine
Precision medicine is an approach to manage finding and making solutions and antibodies that passes on unrivaled results for patients, by fusing clinical and sub-nuclear information to fathom the natural reason of infection. Pharmacometabolomics illuminates and compliments pharmacogenomics and together they give building pieces to Quantitative and Systems Pharmacology. Precision medicine is a rising methodology for illness treatment and avoidance that considers singular variability in qualities, environment, and way of life for every individual. While a few advances in exactness prescription have been made, the practice is not as of now being used for most diseases. Accuracy offers cutting edge answers for augment your achievement in translational examination. The appearance of monstrous parallel sequencing is dependable of an outlook change in biomarker disclosure and clinical trial plan while in transit to what is currently called "biomarker-driven disease solution" or "accuracy pharmaceutical."
Track 4 : Frontiers of Metabolomics Research
Metabolomic studies can incite enhanced cognizance of disease instruments and to new indicative markers furthermore redesigned perception of medication for solution or xenobiotic impact and expanded capacity to anticipate singular variety in medication reaction phenotypes. Howard University Center for Computational Biology and Bioinformatics (CCBB) is to empower and propel the use of computational approaches to manage the examination of biomedical and disease frames. New programming and progressively complex NMR metabolitespectral databases are impelling the fascinating limits of NMR spectroscopy to perceive and assess little particles in answer for examinations of metabolite biomarkers and metabolic flux. MS appreciates a solid point of interest in affectability contrasted and NMR and, through utilization of various blends of chromatographic techniques and mass/charge partition innovations, gives the capacity to gauge a more extensive cluster of little particle metabolites.
Track 5 : Therapeutic Metabolomics
The role of metabolism in invulnerability has been underexplored along these lines, yet then researchers have made basic duties in depicting relationship of safe methods and metabolic pathways. Frameworks immunology means to think about the invulnerable framework in the more coordinated viewpoint on how elements and players take part at various framework levels to the safe function. Computational immunology is a field of science that incorporates high-throughput genomic and bioinformatics ways to deal with immunology.
Track 6 : Transcriptomics & Metabolic pathways
Transcriptomics is worried with deciding how the transcriptome, and subsequently example of quality expression, changes regarding different components, for example, kind of tissue, phase of advancement, hormones, medications, or ailment. It supplements and covers with proteomics. Metabolic pathway is a progression of concoction responses happening inside of a cell. In a pathway, the beginning compound (metabolite) is changed by an arrangement of synthetic responses. These responses are catalyzed by catalysts, where the result of one compound goes about as the substrate for the following. These chemicals frequently require dietary minerals, vitamins, and different cofactors to work.
Track 7 : Metabolic Modelling
Metabolomic profiling is frequently performed with either Nuclear magnetic resonance (NMR) or MS. Individual analytes inside of the specimen are isolated by their attractive reverberation move or mass-to-charge proportion, separately, bringing about an otherworldly profile of partition. At the point when working with natural liquids, NMR regularly does not require substance control of an example, though MS for the most part requires derivatization of metabolites to create ionic species that are all the more promptly isolated by the mass-to-charge proportion. Metabolism is an essential cell procedure, and its glitch can be a noteworthy donor to numerous human sicknesses. Metabolites can serve as a metabolic ailment biomarker. Recognition of such biomarkers assumes a huge part in the investigation of biochemical response and flagging systems.
Track 8 : Clinical Metabolomics & Lipidomics
Metabolomics and lipidomics, extreme mechanical assemblies in systems science, hope to screen little metabolites present in natural illustrations. Contrasts in the species or measures of metabolites can be used to depict phenotypes and common responses to inconveniences. Translational Biomarker Discovery Core fuse recognizing, supporting and making pre-clinical biomarkers for working up the region of illness, observing reduction status, choosing the practicality of specific therapeutic traditions, and controlling the decision of specific accommodating interventions. Biomarkers of ailment could consolidate a wide extent of biochemical components, for instance, nucleic acids, proteins, sugars, lipids, and little metabolites, cytogenetic and cytokinetic parameters and moreover whole tumor cells found in the body fluid. An extensive perception of the relevance of each biomarker will be basic for diagnosing the ailment constantly, and also help in the choice of various healing choices starting now open that is inclined to advantage the patients.
Track 9 : Plant & Environmental Metabolomics
Metabolomics is the examination of endogenous and exogenous low atomic mass metabolites inside of a cell, tissue, or biofluid of a life form in light of an outer stressor. The sub-control of environmental metabolomics is the utilization of metabolomic strategies to investigate the connections of life forms with their surroundings. Drug metabolism system is the procedure by which the body separates and changes over pharmaceutical into dynamic concoction substances. Toxicology is a branch of Medical Science that arrangements with the impacts of synthetic compound utilized as a part of the conclusion, treatment, or counteractive action of ailment or other unusual condition on the body. Plant Metabolomics is to contemplate the plant framework at the sub-atomic level giving non-one-sided characterization of the total metabolite pool (metabolome) of plants under particular conditions. Using Metabolomics, a better understanding of the correlation between genes and the biochemical composition of a plant tissue in response to its environment (phenotype) can be obtained, and this information can be further used to assess gene function (genotype). Four joint U.S. also, Japanese research groups have been recompensed subsidizing totaling about $12 million (about Yen 960 million) to grow new naturally well disposed strategies to expand the creation of renewable biofuel and lessen pesticide use.
Track 10 : Food & Nutritional Metabolomics
Unlike other ‘omics’ technologies (genomics, proteomics…etc), metabolomics gives organic understanding that mirrors an individual's one of a kind hereditary unique mark, as well as way of life, eating routine and environment. Utilizing metabolomics, scientists can quantitatively dissect non-hereditary variables that are included in postgenomic and posttranscriptional change. Nutritional metabolomics is quickly developing to utilize little atom substance profiling to bolster incorporation of eating regimen and sustenance in complex biosystems research. Nutrigenomics is a branch of nutritional genomics and is the study of the effects of foods and food constituents on gene expression. Foodomics has been recently defined as a new discipline that studies food and nutrition domains through the application of advanced omics technologies in which MS techniques are considered indispensable. Applications of Foodomics include the genomic, transcriptomic, proteomic, and/or metabolomic study of foods for compound profiling, authenticity, and/or biomarker-detection related to food quality or safety; the development of new transgenic foods, food contaminants, and whole toxicity studies; new investigations on food bioactivity, food effects on human health. The University of Michigan Nutrition Obesity Research Center (UM NORC) started in 2010, supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The UM NORC is one of 12 U.S. focuses intended to move and backing translational, multi-disciplinary exploration in heftiness and sustenance, over the continuum of fundamental science to applications in people (solution) and populations (public health).
Track 11: Metabolomic devices
Metabolomics, alternately metabonomics, a rising field of biochemical exploration, is a reciprocal procedure to genomics, transcriptomics, and proteomics. Direct quantitative estimations of metabolite expressions in pee, serum, plasma, and tissue are crucial for the investigation of organic procedures in typical and illness states. Subsequent to the quantity of metabolites in a natural example is extensive partition science assumes an imperative part in metabolomic research. Atomic attractive reverberation (NMR) spectroscopy is especially capable for focused investigation since it is quantitative, reproducible, and suitable for complex examples, for example, blood, pee, or tissue removes with practically zero preparing. Thermo Fisher, AB SCIEX, and Bruker likewise offer instruments for imaging MS, additionally called MALDI imaging. To meet difficulties of searchability and information reconciliation, the metabolomics group has a few activities to build up information vaults. Cases are Metabolights in the United Kingdom, bolstered by the European COSMOS (COordination of Standards in MetabOlomicS) consortium that is creating metabolomics information norms, and Metabolomics Workbench, which means to be the database for NIH-subsidized metabolomics ventures. Thermo Fisher teams up with Fiehn on mzcloud.org, a free community database that includes actual and virtual MS spectra with unknown compounds to be annotated as they are identified.
Track 12 : Analytical Platforms in Metabolomics
In metabolomics, real endeavors are put resources into the advancement of suitable scientific methodologies. Metabolomics, the most youngest field in the 'omics family, is growing rapidly. Developing directly behind genomics, transcriptomics, and proteomics, metabolomics is the extensive examination of little particle metabolites. Subsequent to most metabolites are produced by enzymatic proteins that outcome from quality expression, and metabolites give creatures their biochemical attributes, the metabolome links genotype with phenotype. Metabolomics is as yet growing, however, as merchants adjust division and discovery instruments to meet its difficulties and the examination group deciphers and incorporates the mind boggling information they are gaining. The late quick advancement of a scope of investigative stages, including GC, HPLC, UPLC, CE coupled to MS and NMR spectroscopy, could empower partition, identification, portrayal and evaluation of such metabolites and related metabolic pathways. Proceeded with improvement of these diagnostic stages will quicken far reaching use and coordination of metabolomics into frameworks science. NIH Awards $1.6M to Fund microRNA Biomarker Research in Cancer, Alzheimer's Disease . The Bill and Melinda Gates Foundation today declared $7.7 million in financing for 10 new grants to identify biomarkers for diagnosing tuberculosis (TB) in low-resource settings.
Track 13 : Data Analysis & Systems Biology
Systems biology is a field within biology aimed at understanding biological processes at the systems level and emerging from dynamic interactions of individual components operating at multiple spatiotemporal scales. Systems biology considers organic Systems by efficiently bothering them (organically, hereditarily, or artificially); observing the quality, protein, and educational pathway reactions; incorporating these information; eventually, planning numerical models that portray the structure of the framework and anticipate its reaction to individual irritations. Integrated “omics” approaches have made energizing open doors for Systems science and other organic examines. Decreases in the expense of producing genomic information have made DNA sequencing, RNA-seq, and high-throughput screening an undeniably imperative piece of biomedical exploration. The National Institute of General Medicine Sciences (NIGMS), an organization of the National Institutes of Health (NIH) supporting fundamental research and research preparing, declared not long ago that it would build up two new divisions — including one concentrated on biomedical innovation, bioinformatics, and computational biology – – as part of a reorganization that includes the dissolution of the NIH National Center for Research Resources (NCRR) which has had a history of supporting scientific computing.
Track 14 : Enhancing Analytical Approaches
The rapidly growing area of "metabolomics," in which an extensive number of metabolites from body liquids, cells or tissue are identified quantitatively, in a solitary step, guarantees colossal potential for various orders including early infection conclusion, treatment checking, systems biology,drug discovery and nutritional science. In light of its capacity to distinguish countless in place organic specimens reproducibly and quantitatively, nuclear magnetic resonance (NMR) spectroscopy has risen as a standout amongst the most intense diagnostic systems in metabolomics. Metabolon, Aglient Technologies, Thermo Scientific, Chenomx and Human Metabolome Technologies, Biocrates Life Sciences, and Metanomics are the main leaders in the metabolomics space. They are dynamic in numerous parts of this business sector: diagnostics item improvement, profiling administrations, scholarly joint efforts, and even acquisitions. Through the NIH Common Fund's Increasing Metabolomics Research Capacity program External Web Site Policy, the NIH has conferred more than $65 million to quicken the field of metabolomics throughout the following five years. The objective of this financing project is to propel a few center regions, including thorough metabolomics asset centers, metabolomics innovation improvement, metabolomics reference gauges combination, and preparing and instructive exercises in metabolomics.
Track 15 : Case Reports
Case reports are a vital direct wellspring of confirmation in pharmaceutical and a device regularly utilized as a part of practice to trade data and create a more extended quest for proof. A decent case report will be clear about the significance of the perception being accounted for. A good case report will be clear about the importance of the observation being reported. In addition to the “evidence of what happened”, single or multiple cases are an important basis for further and more advanced research on diagnosis, treatment adequacy, reasons and results of ailment. Case reports might be first to give signs in distinguishing another ailment or unfriendly wellbeing impact from a presentation. Case reports must be authentic, understandable, educational and clinically interesting to an international audience of surgeons, trainees and researchers in all surgical subspecialties, as well as clinicians in related fields.
Conference Series LLC welcomes you to attend the 8th International Conference and Exhibition on Metabolomics & Systems Biology during May 11-13, 2017 Singapore. This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists. The main theme of the conference is “Rise of New Era in Metabolomics Research”.
Metabolomics Congress 2017 Conference will be an exploration of New research Innovation of Metabolomics and cover the latest developments and trends in Metabolomics modeling, Proteomics, Systems Biology, Genomics, Precision Medicine, Lipidomics, LC-MS and GC-MS Techniques, Bioinformatics, Plant Metabolomics, Clinical metabolomics, cancer and metabolism, computational biology, metabolomics syndrome, Nutritional Metabolomics, Therapeutic Metabolomics and more. Metabolomics is of interest to physicians because it may lead to improvements in the diagnosis and treatments of human diseases. Conference Series LLC Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide. The global metabolomics market is expected to grow at a strong CAGR during the forecast period of 2014 to 2019 and is estimated to be worth $2,100 million by 2019. The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing.
Metabolomics is an emerging field which combines strategies to identify and quantify cellular metabolites using sophisticated analytical technologies with the application of statistical and multi-variant methods for information extraction and data interpretation. Metabolomics is the study of small metabolites. Metabolomics Conference deals with topics like Bioinformatics, proteomics, systems biology, Analytical Techniques like NMR, GC-MS, LC-MS and CE-MS, Lipidomics, Metabolic Modelling, Metabolic profiling, clinical metabolomics, Translational sciences, Mass spectrometry, Metabolomics Syndrome, HPLC and CE based metabolomics and more. Metabolomics - the new "omics" - is a dynamic and developing field, joining genomics, transcriptomics and proteomics in empowering an integrative frameworks science methodology to drug discovery and development. In spite of the fact that metabolomics is still at an early evolutionary stage it is conjecture that throughout the following decade the biopharma business will apply this innovation all the more generally in drug development and information.
'The Future of Metabolomics' gives fully fledged understanding into the compelling utilization of metabolomics all through drug discovery, preclinical development and clinical trials. The report also highlights the use of metabolomics in maximizing and sustaining revenues post-marketing and in the development of clinical diagnostics.
Importance & Scope:
Metabolomics is now being extensively used in pharmaceutical and biotechnology industries for biomarker and drug discovery; pharmaceutical and biotechnology industries are expected to grow at a high rate in coming years, which is expected to boost the growth of the market.
The National Institutes of Health said that they are to invest $14.3 million for metabolomics research, potentially investing more than $51.4 million over five years, to accelerate an emerging field of biomedical research known as metabolomics. As per National Center for Biotechnology Information. Metabolomics has matured over the past 10 years. Over 300 studies have been completed over the past 5 years.
Why Singapore ?
Singapore’s vision is to be the leading international biomedical sciences cluster, the Biopolis of Asia, a vision shared by many biomedical sciences companies which have chosen Singapore as a preferred base for their business activities in the region. These companies recognise the need to improve R&D productivity and address unmet healthcare needs in Asia.
Singapore’s strong IP laws and welldeveloped trade links have enabled it to attract substantial investment from global research-based pharmaceutical companies, many of which collaborate with Singapore’s research institutes. To further this collaboration, the government has set aside $3.7 billion (local currency rates) to encourage biotechnology research in 2011-15
Currently, seven of the top 10 pharmaceutical and all of the top 10 medical technology companies have their regional headquarters in Singapore, from which they drive their business expansion into Asia. These global leaders include AB SCIEX, Baxter International, Becton Dickinson, BIOTRONIK, GlaxoSmithKline, Hoya Surgical Optics, Life Technologies, Medtronic, Novartis, Siemens Medical Instruments and Takeda.
More than S$1.49 billion is spent on biomedical R&D in Singapore annually. Currently, close to 7,000 researchers carry out biomedical sciences R&D in more than 50 companies, our world-class universities, and 30 public-sector institutes under the Agency for Science, Technology and Research (A*STAR) and the Ministry of Health (MOH).
Looking ahead, Singapore has committed S$19 billion in continued support of research, innovation and enterprise activities between 2016 and 2020. Out of the S$19 billion, the health and biomedical sciences sector gets 21%, the largest share, of the funding with S$4 billion.
Why to attend ???
Meet Your Target Market With recent business reports on Metabolomics making news which manifests the tremendous growth in market value for metabolomics technology till 2019. Since metabolomics interrelated with omics sciences like Genomics, precision Medicine, Proteomics, Lipidomics, Fluxomics and Transcriptomics, it would be a great opportunity for companies dealing with Analytical instruments useful in these fields. Also many upcoming students and researchers can benefit themselves by participating world class International workshops, symposia during the conference which will be conducted by experts in the respective fields.
Major Metabolomics Related Associations around the Globe :
Major Metabolomics Related Research Units in Singapore :
NERI - National University of Singapore
Singapore Centre for Environmental Life Sciences Engineering
Duke-NUS Medical School
Singapore-MIT Alliance for Research and Technology
Genome Institute of Singapore (GIS) - A Star
Singapore National Academy of Science
The National Research Foundation (NRF), Singapore
Nanyang Technological University
James Cook University Singapore
German Institute of Science and Technology
Rise in the number of clinical trials, toxicological studies, and health awareness for nutritional products, rapid growth of metabolomics data analysis software and solutions, and use of metabolomics as diagnostics tool for biomarker screening of diseases is expected to propel the growth of this market.
Glance at Market of Metabolomics:
The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing. However, low adoption rates and data complexity inhibits the growth of the metabolomics market to a certain extent. Metabolomics science is used extensively in biomarker discovery and drug assessment. Thus, the rapid growth experienced by pharmaceutical and biotechnology industries is assisting the growth of the metabolomics market.
Statistics which shows growth in importance of Metabolomics :
Metabolomics Market Worth $2,100 Million by 2019 - New Report by Markets and Markets.
Statistics of Industries Associated with Metabolomics :
North America was the market leader with a share of ~42% of the global market, followed by Europe with a share of ~38%. The presence of a large number of analytical equipment manufacturers has contributed significantly to the North American and European metabolomics market. However, the Asia-Pacific region represents a significant growth opportunity for the metabolomics market during the forecast period of 2014 to 2019. The APAC market is expected to grow at a CAGR of 23% during the forecast period. The growth in this market is driven by the growing pharmaceutical and biotechnology industries.
Fund Allotment towards Metabolomics Research :
The National Institutes of Health has provided tens of millions of dollars in new funding to support three new Comprehensive Metabolomics Centers at Mayo Clinic, the University of Kentucky, and the University of Florida.
These three centers will receive an estimated $9 million to $10 million each over the next five years to create resources and initiate research programs that will ramp up the national metabolomics science capabilities.
- Michigan Regional Comprehensive Metabolomics Resource Core (MRC2)
- NIH West Coast Metabolomics Center at UC Davis
- Southeast Center for Integrated Metabolomics (SECIM)
- Metabolomics Core at Mayo Clinic
- Research Center for Stable Isotope Resolved Metabolomics
Metabolomics Congress 2016 Report
The 5th International Conference and Exhibition on Metabolomics, Metabolomics Congress 2016 was held in Osaka, Japan, during May 16 - 18, 2016.
Metabolomics Congress 2016 has welcomed the new era of Metabolomics; a futuristic arena for treatment of diseases, clasping a promising tomorrow. The highly exalted conference hosted by Conference Series LLC was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 20 countries around the world. The conference has tried grounding every aspect related to Metabolomics and Cancer, covering all the possible research areas and crux.
The conference aimed a parallel rail with theme “Fifty Shades of Metabolomics and Methodological Development”. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Metabolomics and Cancer Research, Analytical Techniques in Metabolomics, Applications of Separation Sciences in Metabolomics, Frontiers of Metabolomics Research, Systems biology and Computational Biology, Bioinformatics and Advancements, Clinical Metabolomics and Lipidomics, to mention a few. The three days event implanted a firm relation of upcoming strategies in the field of Metabolomics with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.
We are thankful to all our speakers for encouraging and supporting us to conduct the conference and catapulting the same to pinnacle of success.
The Organizing Committee would like to thank the moderators Dr. Eugenia Trushina, Mayo Clinic, USA and Dr. Houkai Li, Shanghai University of Traditional Chinese Medicine, China for their contributions which resulted in smooth functioning of the conference.
A series of invited lectures by Honorable guests and members of the Keynote Forum marked the commencement of the event. Prominent scientists like Petras Dzeja from Mayo Clinic, USA; Horng-Mo Lee from Taipei Medical University, Taiwan; Eugenia Trushina from Mayo Clinic College of Medicine, USA; Jian Zhi Hu from Pacific Northwest National Laboratory, USA; Loeffler Jean Philippe Université de Strasbourg, France; Björn Riefke from Bayer Pharma AG, Germany; Sam F Y Li, from National University of Singapore, Singapore; Ashkan Emadi from University of Maryland School of Medicine, USA; Houkai Li from Shanghai University of Traditional Chinese Medicine, China; gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.
Conference Series LLC is prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on transcribing the plenary sessions and workshops in a diversified and variegate manner to make this conference an enviable artefact.
Conference Series LLC offers its heartfelt appreciation to our sponsor “Denator. Sweden”. We also express our sincere thanks to all the media partners for the promotion of our event to glory.
The supporting Sponsor who continuously show confidence in our conferences were Denator.
The best poster presentations were awarded by Dr. Björn Riefke Bayer Pharma AG, Germany to:
Fatin Najwa, Universiti Putra Malaysia, Malaysia
Mei-Chen Lo, Taipei Medical University, Taiwan
Yoriko Heianza, Tulane University, USA
Conference Series LLC, on behalf of the conference, congratulates the Best poster awardees for their outstanding performance in the field of Metabolomics and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.
Conference Series LLC 5th International Conference and Exhibition on Metabolomics would not have reached the pinnacle if not with the support of international, multi-professional steering committee and coordination of the Journal of Metabolomics: Open Access, Journal of Computer Science and Systems Biology; hence, we express our deep sense of gratitude.
After the successful completion of six consecutive conferences we are glad to announce our next upcoming conferences which is going to be held in UAE and USA are,
“7th International Conference and Exhibition on Metabolomics” which is going to be held during Nov 14-16, 2016 in Florida, USA.
“8th International Conference and Exhibition on Metabolomics” which is going to be held during May 11-13, 2017 in Dubai, UAE.
Mark your calendars; we are hoping to see you soon!
Past Reports Gallery Metabolomics-2015
The 4th International Conference and Exhibition on Metabolomics and Systems Biology, Metabolomics-2015 was held in Philadelphia, USA, during April 27 - 29, 2015.
Metabolomics-2015 has welcomed the new era of Metabolomics and Systems Biology; a futuristic arena for treatment of diseases, clasping a promising tomorrow. The highly exalted conference hosted by OMICS International was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 20 countries around the world. The conference has tried grounding every aspect related to Metabolomics and Systems Biology, covering all the possible research areas and crux.
The conference aimed a parallel rail with theme “Metabolomics Technology and Omics Sciences - A Roadmap for Advanced Research Initiatives”. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Metabolomics and Cancer Research, Analytical Techniques in Metabolomics, Applications of Separation Sciences in Metabolomics, Frontiers of Metabolomics Research, Systems biology and Computational Biology, Bioinformatics and Advancements, Clinical Metabolomics and Lipidomics, to mention a few. The three days event implanted a firm relation of upcoming strategies in the field of Metabolomics and Systems Biology with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.
We are thankful to all our speakers for encouraging and supporting us to conduct the conference and catapulting the same to pinnacle of success.
The Organizing Committee would like to thank the moderators Scott J Tebbutt, University of British Columbia, Canada and Dr. John M Pisciotta, West Chester University, USA, for their contributions which resulted in smooth functioning of the conference.
A series of invited lectures by Honorable guests and members of the Keynote Forum marked the commencement of the event. Prominent scientists like Mukesh Verma from National Institutes of Health, USA; Stefan Kempa from BIMSB, Germany; Marvin W Makinen from The University of Chicago, USA; Paola A Marignani from Dalhousie University, Canada; Ih-Jen Su National Health Research Institutes, Taiwan; Deliang Guo from The Ohio State University, USA; Sam F Y Li, from National University of Singapore, Singapore; Asha R Kallianpur from Cleveland Clinic Lerner College of Medicine, USA; Houkai Li from Shanghai University of Traditional Chinese Medicine, China; gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.
The supporting Sponsors who continuously show confidence in our conferences were NASA, Thermo Scientific and Premier Biosoft.
The best poster presentations were awarded by Dr. Sam F Y Li National University of Singapore, Singapore to:
Chi-Wen Huang, China Medical University, Taiwan
Paolo Schiavini, McGill University, Canada.
OMICS International, on behalf of the conference, congratulates the Best poster awardees for their outstanding performance in the field of Metabolomics and Systems Biology and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.
OMICS 4th International Conference and Exhibition on Metabolomics and Systems Biology would not have reached the pinnacle if not with the support of international, multi-professional steering committee and coordination of the Journal of Metabolomics: Open Access, Journal of Computer Science and Systems Biology; hence, we express our deep sense of gratitude.
We are overwhelmed to announce the 5th International Conference and Exhibition on Metabolomics and Systems Biology, as a continuum of the four successful conferences. The event will be held during May 30-June 01, 2016 in Osaka, Japan. Mark your calendars; we are hoping to see you soon!
Past Reports Gallery Metabolomics-2014
On March 24-26, 2014, OMICS at Hilton San Antonio Airport, USA organized its 3rd International Conference and Exhibition on Metabolomics & Systems Biology. This conference was a continued success achieved by OMICS Group Conference towards the advanced and innovative transitions occurring in the scientific field with researchers, university professors, industrialists, business delegates, young research minds and students.
The Conference began with an overwhelming and much applauded opening ceremony by Dr. Jeff Patrick and Dr. Vladimir Bondarenko followed by Keynote sessions. The Keynote speakers for the conference were: Bernd Schneider, Max Planck Institute for Chemical Ecology, Germany, Vladimir V. Tolstikov, Eli Lilly & Company, USA, Chris Beecher, IROA Technologies, USA and Stephen E. Reichenbach University of Nebraska, USA.
Metabolomics-2014 Organizing Committee would like to thank the Moderator of the conference, Dr. Vladimir E Bondarenko, Georgia State University, USA who contributed a lot for the smooth functioning of this event.
OMICS Group International would like to convey a warm gratitude to all the Honorable guests of Metabolomics-2014:
Chris Beecher, IROA Technologies USA
Vladimir V. Tolstikov, Eli Lilly & Company, USA
Jeffrey S. Patrick, LECO Corporation, USA
Carolus Reinecke, Manager of the National Metabolomics Platform, South Africa
OMICS Group, on behalf of the conference, congratulates the Best poster awardees for their outstanding performance in the field of Metabolomics and Systems Biology and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.
OMICS Group also took the privilege of felicitating Metabolomics-2014 Organizing Committee, Editorial Board Members of Metabolomics: Open Access, Journal of Computer Science & Systems Biology and Global Journal of Technology and Optimization,Keynote Speakers, Chair and Co-Chairs whose support made conference a great success. The Keynote sessions, introductory speeches by honorable guests, and all the other sessions highlighted the recent advancements, challenges, issues, opportunities, research ideas and innovations in metabolomics and systems biology research, that was reflected by the theme of the conference “Multi-Omic Approaches to Envision the Role of Metabolites in Biological Systems." The theme embarked upon various topics like Novel approaches in cancer therapeutics, Analytical and bioanalytical techniques, computational biology, proteomics, genomics, metabolomics syndrome which all together proved to bring about quality presentations.
The supporting Sponsors who continuously show confidence in our conferences were ABSCIEX, Thermo Scientific and Biocrates Life Sciences AG. The luncheon workshop conducted by ABSCIEX at our conference had an overwhelming response.
The best poster presentations were awarded by Dr. Vladimir Bondarenko to:
Richard Chang, Texas A&M University, USA.
Lakshmi Prasuna, University of Hyderabad, India.
Jong Min Choi, Ewha Womans University, Republic of Korea.
Patiolla Madhukar Reddy, GVK Biosciences Private Limited, India.
Wei Xiong, NREL, USA
OMICS Group acknowledges and appreciates the continuous support from all the organizing committee members, chair and co-chair, editorial board members of OMICS Group Journals, speakers, business delegates, students, sponsors, exhibitors, media partners and special thanks to moderator in making this event a great success.
Thank you to everyone for your valuable support and cooperation. Persuaded with positive accolades from the scientific community OMICS Group moves a step ahead in the pursuit of organizing consecutive successful conference with continued support and cooperation from scientific community furthering the platform for metabolomics and systems biology research with concomitant approach with omics sciences.
For Metabolomics-2014 proceedings please visithttp://omicsonline.org/ArchiveJOM/metabolomics-systems-biology-2014-proceedings.php
OMICS therefore, is glad to announce its "4th International Conference and Exhibition on Metabolomics and Systems Biology" which will be held during April 27-29, 2015 at Philadelphia, USA.
Past Reports Gallery Metabolomics-2013
The 2nd International Conference and Exhibition on Metabolomics & Systems Biologywas organized by the OMICS Group during April 08-10, 2013 at Hilton Suites Chicago/Northbrook, USA. Generous response and active participation was received from the Researchers, Omics Professionals, Principal Investigators from NIH, NASA, USFDA & US Army.
Organizing Committee Members, Editorial Board Members of OMICS Group and Delegates representing 35 countries made the conference a success. The conference was initiated with a series of invited lectures delivered by both Honorable Guests and members of the Keynote Forum.
Dr. John Ryals, Metabolon Inc., USA
Dr. Chris Beecher, NextGen Metabolomics, USA
Dr. Mukesh Verma, National Institutes of Health, USA
Dr. Paul L. Wood, Lincoln Memorial University, USA
Dr. Christoph H. Borchers, University of Victoria, Canada
Dr. Jeffrey S. Patrick, LECO Corporation, USA
Workshop titled “NASA Omics” moderated by Dr. Viktor Stolc, NASA Ames Research Center, USA added novel approach of Omics application in Space Biology Research.
Our Sincere appreciation to BIOCRATES Life Sciences AG, IsoSciences, Waters Corporation, Cambridge Isotope Laboratories, Inc., Thermo Fisher Scientific andABSciex for their tireless efforts towards designing of new tools and techniques in the sea of Metabolomics and Systems Biology. We understood your seriousness towards finding solutions for the problems encountered in the vast field of Metabolomics.
OMICS Group felicitated all the Organizing Committee Members and Editorial Board Members who enthusiastically participated in the conference and made this meeting a huge success. OMICS Group on behalf of Sponsors and Exhibitors congratulate all the Best Poster Awardees for their outstanding contribution in the field of Metabolomics and Systems Biology, simultaneously encourages all the participants who tried to put their efforts in poster presentations and wish them success for their future research.
BIOCRATES Life Sciences AG Best Poster: Samrina Rehman, University of Manchester, UK
Thermo Fisher Scientific Best Poster: Jun Han, University of Victoria, Canada
Waters Corporation Best Poster: Sarah Gentry, Genzyme - A Sanofi Company, USA
IsoSciences Best Poster: Hyung Jun Noh, National Institute of Horticultural & Herbal Science, Korea
ABSciex Best Poster: Jeffrey H. Dahl, Shimadzu Scientific Instruments, USA
Cambridge Isotope Laboratories Best Poster: Mohammad Ghazizadeh, Nippon Medical School, Japan
With the unique feedback from the conference, OMICS Group would like to announce the "3rdInternational Conference and Exhibition on Metabolomics & Systems Biology” during March 24-26, 2014 in San Antonio, USA.
Past Reports Gallery
- Metabolomic profiling
- Metabolomic Database
- Metabolomic Analysis
- Human Metabolomics
- Single Cell Metabolomics
- Mass Spectrometry based Metabolomics
- Urine Metabolomics
- Clinical Metabolomics & Lipidomics
- Cancer Therapeutic Approaches
- Plant & Environmental Metabolomics
- Metabolic Syndrome
- Metabolomics in Precision Medicine
- Food & Nutritional Metabolomics
- Frontiers of Metabolomics Research
- Metabolomic Devices
- Therapeutic Metabolomics
- Analytical Platforms in Metabolomics
- Transcriptomics & Metabolic pathways
- Data Analysis & Systems Biology
- Enhancing Analytical Approaches
- Metabolic Modelling
- Case Reports
Click here to submit abstract to any of the above topics
Want to Differentiate your company from your competitors and broaden your competitive edge?
Use our global platform of 3000+ Global Events
- 25 Million+ Visitors to our Global website (conferenceseries.com)
- 20000+ Unique Visitors per conference
- 60000+ Page views per conference
To share your views and research, please click here to register for the Conference.